Bayesian Neurobehavioral Phenotyping: From Mechanism Identification to Personalized Neuromodulation Treatments. R61 PHASE
Clinical trial NCT06991062 · RECRUITING
Trial details
- NCT number
- NCT06991062
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-19
- Primary completion
- 2026-12-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.